ArticleOncology reports2019

Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.

Hongyue Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.